Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Gbenga Akinbiyi"'
Autor:
Amina Mohammed, Lois Olajide, Gbetsere Aghogho, Chioma Dan-Nwafor, Chimezie Anueyiagu, Sola Sunday Thomas, Adaora Rosemary Ejikeme, Famokun Gboyega, Gbenga Akinbiyi, Bola Biliaminu Lawal, Muhammad Shakir Balogun
Publikováno v:
East African Journal of Health and Science. 3:115-125
Background: Lassa fever (LF) is an acute viral haemorrhagic illness of a 2–21-day incubation period that occurs in West Africa. It is endemic in Nigeria and peaks during the first 12 weeks of the year. On January 22, 2019, the Nigeria Centre for Di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::01f8c71fa2d825a9be696c7400ea6083
https://doi.org/10.37284/eajhs.3.1.379
https://doi.org/10.37284/eajhs.3.1.379
Autor:
Jay Osi Samuels, Alani S Akanmu, Prosper Okonkwo, Solomon Odafe, Gbenga Akinbiyi, Oluwafunke Ilesanmi, Hadiza Khamofu, Seth C Inzaule, Isaac F. Adewole, Nicaise Ndembi, Emmanuel Abatta, Rex Mpazanje, Phyllis J. Kanki, Tobias F. Rinke de Wit, Chukwuemeka Asadu, Kim C. E. Sigaloff, Evelyn Ngige, Beth Chaplin, Patrick Dakum
Publikováno v:
Journal of Antimicrobial Chemotherapy, 74(1), 172-176. Oxford University Press
Journal of antimicrobial chemotherapy, 74(1), 172-176. Oxford University Press
Chaplin, B, Akanmu, A S, Inzaule, S C, Samuels, J O, Okonkwo, P, Ilesanmi, O, Adewole, I F A, Asadu, C, Khamofu, H, Mpazanje, R, Ndembi, N, Odafe, S, Sigaloff, K C E, Ngige, E N, Abatta, E O, Akinbiyi, G, Dakum, P, Rinke de Wit, T F & Kanki, P 2019, ' Association between HIV-1 subtype and drug resistance in Nigerian infants ', Journal of Antimicrobial Chemotherapy, vol. 74, no. 1, pp. 172-176 . https://doi.org/10.1093/jac/dky380
Journal of antimicrobial chemotherapy, 74(1), 172-176. Oxford University Press
Chaplin, B, Akanmu, A S, Inzaule, S C, Samuels, J O, Okonkwo, P, Ilesanmi, O, Adewole, I F A, Asadu, C, Khamofu, H, Mpazanje, R, Ndembi, N, Odafe, S, Sigaloff, K C E, Ngige, E N, Abatta, E O, Akinbiyi, G, Dakum, P, Rinke de Wit, T F & Kanki, P 2019, ' Association between HIV-1 subtype and drug resistance in Nigerian infants ', Journal of Antimicrobial Chemotherapy, vol. 74, no. 1, pp. 172-176 . https://doi.org/10.1093/jac/dky380
Background: Many lines of evidence point to HIV-1 subtype-specific differences in the development of drug resistance mutations. While variation between subtype C and others has been extensively explored, there has been less emphasis on subtypes commo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88c1e2b18695e10c57cb3d43845a0c10
https://research.vumc.nl/en/publications/65334456-df4f-48b1-9d6a-ce904d024efb
https://research.vumc.nl/en/publications/65334456-df4f-48b1-9d6a-ce904d024efb
Autor:
Nicaise Ndembi, Asadu Emeka, Samuels Jay Osi, Hadiza Khamofu, Solomon Odafe, Gbenga Akinbiyi, Sulaimon Akanmu, Seth C Inzaule, Tobias F. Rinke de Wit, Kim C. E. Sigaloff, Rex Mpazanje, Oluwafunke Ilesanmi
Publikováno v:
Journal of acquired immune deficiency syndromes (1999), 77(1), E1-E7
Journal of acquired immune deficiency syndromes (1999), 77(1), e1-e7. Lippincott Williams and Wilkins
Inzaule, S C, Osi, S J, Akinbiyi, G, Emeka, A, Khamofu, H, Mpazanje, R, Ilesanmi, O, Ndembi, N, Odafe, S, Sigaloff, K C E, Rinke de Wit, T F & Akanmu, S 2018, ' High Prevalence of HIV Drug Resistance Among Newly Diagnosed Infants Aged <18 Months : Results From a Nationwide Surveillance in Nigeria ', Journal of acquired immune deficiency syndromes (1999), vol. 77, no. 1, pp. E1-E7 . https://doi.org/10.1097/QAI.0000000000001553
Journal of acquired immune deficiency syndromes (1999), 77(1), e1-e7. Lippincott Williams and Wilkins
Inzaule, S C, Osi, S J, Akinbiyi, G, Emeka, A, Khamofu, H, Mpazanje, R, Ilesanmi, O, Ndembi, N, Odafe, S, Sigaloff, K C E, Rinke de Wit, T F & Akanmu, S 2018, ' High Prevalence of HIV Drug Resistance Among Newly Diagnosed Infants Aged <18 Months : Results From a Nationwide Surveillance in Nigeria ', Journal of acquired immune deficiency syndromes (1999), vol. 77, no. 1, pp. E1-E7 . https://doi.org/10.1097/QAI.0000000000001553
BACKGROUND: WHO recommends protease-inhibitor-based first-line regimen in infants because of risk of drug resistance from failed prophylaxis used in prevention of mother-to-child transmission (PMTCT). However, cost and logistics impede implementation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04f2bdc7bd8ccbf84aa31055e4141bbd
https://pubmed.ncbi.nlm.nih.gov/28961680
https://pubmed.ncbi.nlm.nih.gov/28961680